Study to Assess OCT: RNFL and GCL in MS Patients

NCT03313843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2021-06-02

No results posted yet for this study

Summary

The purpose of this study is to collect preliminary data on retinal nerve fiber layer and ganglion cell layer damage in multiple sclerosis (MS) patients, using optical coherence tomography (OCT). For this study the Zeiss Cirrus OCT Imaging System will be used. The same system will be used consistently for the duration of the study.

Conditions

Sponsors & Collaborators

  • Tampa Bay Uveitis Center, LLC

    lead OTHER

Principal Investigators

  • Grace Levy-Clarke, M.D. · Tampa Bay Uveitis Center, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-09
Primary Completion
2020-12-17
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03313843 on ClinicalTrials.gov